Stand-alone XLIF: 22 consecutive patients with degenerative scoliosis and foraminal stenosis in a 2-year follow-up
More details
Hide details
Sector for Spine Surgery and Research, Middelfart Hospital, Denmark
Submission date: 2014-09-02
Acceptance date: 2015-03-09
Online publication date: 2015-04-20
Publication date: 2020-03-24
Corresponding author
Emil Jesper Hansen   

Sector for Spine Surgery and Research, Middelfart Hospital, Østre Hougvej 55, Middelfart 5500, Denmark. Tel.: +45 22 13 67 20; fax: +45 63 48 42 81.
Pol. Ann. Med. 2015;22(1):1–4
Adult thoracolumbar degeneration is an increasing challenge in the aging population. With age the progressive degeneration of the discs leads to an asymmetric collapse and a thoracolumbar coronal plane deformity, a degenerative scoliosis (DS).

To evaluate the complication rate and clinical/radiological results in 22 patients treated with XLIF procedure for DS or degenerative disc disease (DDD).

Material and methods:
22 consecutive patients with DS underwent surgery with the XLIF stand-alone procedure, with follow-up of 24 months. Clinical outcome scores were collected. Complications were recorded.

Results and discussion:
22 patients, mean age of 65 years (48–81), underwent surgery on 49 levels (1–4) between L1 and L5. VAS for leg pain improved from 5.94 to 3.5 (P < 0.05) and back pain from 5.91 to 3.7 (P < 0.05). EQ 5D-3L improved from 0.29 to 0.62 (P < 0.05). Seven patients (31.8%) underwent revision surgery. Fusion was achieved in 53% (25/49) at 1-year follow-up. Anterior thigh pain was reported in 12 patients postoperatively, and in 2 patients at 1-year follow-up.

The XLIF stand-alone procedure improves clinical outcome scores significantly after 1- and 2-year follow-up, with a 31.8% revision rate. Due to the high revision rate we recommend supplementary posterior instrumentation, to achieve a higher fusion rate. When considering XLIF-stand-alone procedure for DS or DDD without supplemental posterior instrumentation, only single-level disease should be advised, taking sagittal parameters into account.

None declared.
Oskouian Jr RJ, Shaffrey Cl. Degenerative lumbar scoliosis. Neurosurg Clin N Am. 2006;17:299–315.
Watanuki A, Yamata H, Tsutsui T, En-yo Y, Yoshida M, Yoshimura N. Radiographic features and risk of curve progression of de-novo degenerative lumbar scoliosis in the elderly: a 15 year follow-up study in a community-based cohort. J Orthop Sci. 2012;17(5):526–531.
Deluzio KJ, Lucio JC, Rodgers WB. Value and cost in less invasive spinal fusion surgery: lessons from a community hospital. SAS J. 2010;4:37–40.
Ozgur BM, Aryan HE, Pigmenta L, Taylor WR. Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J. 2006;6:435–443.
Isaacs RE, Hyde J, Goodrich JA, Rodgers WB, Phillips FM. A prospective, nonrandomized, multicenter evaluation of extreme lateral interbody fusion for the treatment of adult degenerative scoliosis. Spine J. 2010;35(Suppl. 26):S322–S330.
Phillips FM, Isaacs R, Rodgers WB, et al. Adult degenerative scoliosis treated with XLIF. Spine J. 2013;38:1853–1861.
Fujita T, Kostuik JB, Huckell CB, Sieber AN. Complications of spinal fusion in adult patients more than 60 years of age. Orthop Clin North Am. 1998;29:669–678.
Nemani VM, Aichmar A, Taher F, et al. Rate of revision surgery after stand-alone lateral lumbar interbody fusion for lumbar spinal stenosis. Spine J. 2014;39(5):E226–E331.
Rogers WB, Gerber EJ, Patterson BA. Intraoperative and early postoperative complications in extreme lateral interbody fusion. Spine J. 2010;36:26–33.
Yamada K, Matsuda H, Nabeta M, Habunaga H, Suzuki A, Nakamura H. Clinical outcomes of microscopic decompression for degenerative lumbar foraminal stenosis: a comparison between patients with and without degenerative lumbar scoliosis. Eur Spine J. 2010;20(6):947–953.
Malham G, Ellis NJ, Parker RM, Seex KA. Clinical outcome and fusion rates after the first 30 extreme lateral interbody fusions. ScientificWorldJournal. 2012;246989.
Lykissas MG, Aichmair A, Sama AA, et al. Nerve injury and recovery after lateral interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study. Spine J. 2014;14:217–224.